February 3, 2026 · Form 4 insider transaction
Smith Jason Drew sold 3,217 shares of UROGEN PHARMA LTD at $19.69 per share, a transaction worth $63.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 8 days after the transaction.
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.